Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metabolic changes associated with antipsychotic use.

Joseph A Lieberman1

  • 1Jefferson Medical College, Philadelphia, Pennsylvania, USA. jlieberman@jalmd.com

Primary Care Companion to the Journal of Clinical Psychiatry
|July 8, 2005
PubMed
Summary

Physicians must recognize that schizophrenia and bipolar disorder increase diabetes risk. Proactive management of metabolic syndrome and atypical antipsychotic side effects is crucial for patient well-being.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Excessive sleepiness and self-reported shift work disorder: an Internet survey of shift workers.

Postgraduate medicine·2013
Same author

2011 recommendations for the diagnosis and management of gout and hyperuricemia.

The Physician and sportsmedicine·2012
Same author

2011 Recommendations for the diagnosis and management of gout and hyperuricemia.

Postgraduate medicine·2011
Same author

Treatment and prophylaxis of gout flare in the clinic: an office-based approach to gout management.

Postgraduate medicine·2011
Same author

Identifying depression in primary care.

Postgraduate medicine·2009
Same author

Insomnia in primary care: overcoming diagnostic and treatment barriers. Introduction.

Postgraduate medicine·2009

Area of Science:

  • Medical Science
  • Psychiatry
  • Endocrinology

Background:

  • Type 2 diabetes is reaching epidemic levels in the U.S.
  • Schizophrenia and bipolar disorder are often overlooked as risk factors for diabetes.
  • Metabolic syndrome (Syndrome X) is a significant concern in schizophrenia patients.

Purpose of the Study:

  • To highlight the increased risk of type 2 diabetes in patients with schizophrenia and bipolar disorder.
  • To inform physicians about the link between schizophrenia and metabolic syndrome.
  • To emphasize the need for proactive management of metabolic risks associated with atypical antipsychotic treatment.

Main Methods:

  • Review of current medical literature on diabetes, schizophrenia, bipolar disorder, and metabolic syndrome.
  • Analysis of the impact of atypical antipsychotics on metabolic health.
  • Discussion of clinical considerations for managing comorbid conditions.

Main Results:

  • Schizophrenia and bipolar disorder are associated with a higher incidence of type 2 diabetes.
  • Metabolic syndrome, characterized by weight gain and dyslipidemia, is prevalent in schizophrenia patients.
  • Atypical antipsychotics can exacerbate metabolic risks, including hypertriglyceridemia and insulin resistance.

Conclusions:

  • Physicians must be vigilant about the elevated diabetes risk in patients with serious mental illnesses.
  • Balancing the benefits of antipsychotic treatment with metabolic adverse effects is essential.
  • Failure to manage mental illness due to metabolic concerns can lead to worse patient outcomes.

Related Experiment Videos